Discover what makes us a different kind of CDMO at CPHI Milan 2024, booth #7B18
This poster discusses a stepwise Quality-by-Design (QbD) approach consistent with ICH Q8 (R2) and associated regulatory guidelines to build quality into a Novel ALS drug product.
Ready to discuss your project?
Connect with us
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.